Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)
Research Question:
Does convalescent plasma help treat participants who are COVID-19 positive?
Basic Study Information
Purpose:
The purpose of this study is to is to determine if convalescent plasma will help in
reducing hospitalization and death in participants with a postive COVID-19 test and
have developed symptoms of COVID-19. COVID-19 symptoms include but are not limited
to fever, cough, or loss of test or smell. You must be 18 years or older to participate.
Location: Clinical Research Center
Study Reference #: 4965
Lead Researcher (Principal Investigator)
Lead Researcher:
Martin Zand
Study Contact Information
Study Coordinator: Susanne Heininger
Phone: (585) 273-1926
Email: Susanne_Heininger@URMC.Rochester.edu
Additional Study Details
Number of Visits:
2 to 5
Parking:
Free
Transportation Coverage:
No
Reimbursement:
Yes
Trial Not Found
The study you are looking for is not active at this time.
Return to Search